TOXICOLOGY LETTERS is a prominent journal dedicated to advancing the field of toxicology, providing a platform for high-quality research and reviews that explore the effects of chemical substances on biological systems. Published by Elsevier Ireland Ltd, this peer-reviewed journal has established itself as a vital resource in toxicological research since its inception in 1977, with a convergence of studies extending to 2024. With an impressive Scopus ranking, positioned at #28 out of 133 in the Toxicology category, TOXICOLOGY LETTERS garners a respectable percentile of 79, highlighting its significance in the academic community. Although it is not an open-access journal, its research is accessible through institutional subscriptions, ensuring that critical insights into human health and environmental safety are disseminated effectively. Being categorized in the Q2 quartile in both Medicine (miscellaneous) and Toxicology for 2023 further emphasizes its relevance and impact in these fields. This journal aims to foster collaboration between researchers and professionals, encouraging the exploration of innovative solutions to chemical hazards and the promotion of safer practices in pharmacology and toxicology.

TOXICOLOGICAL SCIENCES, published by Oxford University Press, is a premier journal in the field of toxicology that has been a cornerstone of scientific discourse since its inception in 1981. With an impressive 2023 impact factor and ranked in the Q1 category for Toxicology, this journal is highly regarded among researchers, professionals, and students dedicated to pharmacology and toxicology. The journal is committed to advancing the understanding of toxicological science, covering a breadth of topics that include the mechanisms of toxicity, risk assessment, and the regulatory aspects affecting public health. With an ISSN of 1096-6080 and an E-ISSN of 1096-0929, TOXICOLOGICAL SCIENCES facilitates open access scholarly work, ensuring that critical research reaches a global audience and promotes collaborative learning. As it converges towards 2024, the journal remains pivotal in shaping the future of toxicology research, providing insights that are essential for developing safer chemicals and protecting environmental health.

Toxics is a leading international journal published by MDPI that has been dedicated to advancing the knowledge in the fields of toxicology, environmental health, and chemical safety since its inception in 2013. With an impressive Open Access model, it ensures that all research findings are readily available to a global audience, fostering collaboration and innovation across academia and industry. The journal is esteemed for its rigorous peer-review process and holds notable rankings, including Q1 status in Chemical Health and Safety and Q2 in both Health, Toxicology and Mutagenesis and Toxicology, reflecting its impact on critical research areas. Based in Basel, Switzerland, Toxics provides a platform for researchers, professionals, and students to disseminate significant findings on the implications of toxic substances in health and the environment, aiming to improve public health outcomes and inform regulatory decisions. With its ongoing commitment to high-quality research and relevant access options, Toxics continues to be an essential resource in the domain of toxicology and environmental sciences.

Molecular & Cellular Toxicology, published by the Korean Society Toxicogenomics & Toxicoproteomics (KSTT), is a significant journal in the field of toxicology, providing crucial insights into molecular mechanisms underlying toxic responses. With an ISSN of 1738-642X and E-ISSN 2092-8467, this journal serves as a vital platform for researchers, professionals, and students interested in the latest findings and advancements in toxicology, health, and environmental science. Although it operates under a subscription model, it maintains rigorous peer review standards, contributing to its respectable Q3 classification in Health, Toxicology and Mutagenesis, and its Q2 standing in Pharmacology, Toxicology, and Pharmaceutics. The journal, intersecting with innovative aspects of pharmacology and public health, aims to foster a deeper understanding of toxicological impacts on cellular processes and overall health. Located in Germany and supported by a dedicated editorial board, Molecular & Cellular Toxicology stands out in the academic community, encouraging interdisciplinary discourse and collaboration to address critical toxicological challenges. Engage with us for cutting-edge research that informs and shapes the future of toxicological science.

The Journal of Environmental Science and Health Part C-Toxicology and Carcinogenesis is a vital publication in the fields of environmental science, toxicology, and cancer research, published by Taylor & Francis Inc. With an ISSN of 2689-6583 and E-ISSN 2689-6591, this journal provides a platform for peer-reviewed research that explores the intersection of environmental factors and health outcomes, particularly focusing on toxicological and carcinogenic impacts. Though it does not currently offer Open Access, it remains a significant contributor to academia with its current ranking in the Q4 category for Cancer Research and Q3 in Health, Toxicology and Mutagenesis. The journal has converged from 2020 to 2024 and aims to disseminate pioneering studies that inform public health policies and foster a deeper understanding of environmental toxins. Aspiring researchers, professionals, and students will find this journal to be an essential resource for the latest findings and discussions within these critical fields.

Current Research in Toxicology is a pioneering journal published by ELSEVIER that serves as a vital platform for disseminating cutting-edge research in the field of toxicology, spanning from biological impacts to pharmacological applications. With an ISSN of 2666-027X and an impressive Q2 ranking in key categories such as Applied Microbiology and Biotechnology, Health, Toxicology and Mutagenesis, and Toxicology, this journal underscores its commitment to high-quality research and significant contributions to the scientific community. Based in the Netherlands, Current Research in Toxicology aims to bridge the gap between academia and industry by providing rigorously peer-reviewed articles that cover a wide array of topics including novel methodologies, regulatory challenges, and emerging trends within the domain. The journal is accessible through various platforms, making it essential for researchers, professionals, and students eager to stay updated on the latest findings and advancements in toxicology. With a comprehensive focus on integrating theory with practical application, this journal is poised to influence future studies and policies in health and environmental science.

Particle and Fibre Toxicology is a leading open-access journal dedicated to advancing the field of toxicology, specifically focusing on the health impacts of particulate matter and fibers. Published by BMC since 2004, this journal operates from its offices in the United Kingdom and has gained significant recognition in the scientific community, achieving an impressive impact factor that highlights its relevance and influence. As indicated by its Q1 ranking in various categories including Health, Toxicology and Mutagenesis and Medicine (miscellaneous), it occupies a prestigious position in the academic landscape, appealing to researchers, professionals, and students alike. With a Scopus ranking of #4 in Toxicology and #7 in Environmental Science, the journal ensures high visibility and accessibility, providing a platform for the dissemination of key research findings and innovative methodologies in the interdisciplinary domains of toxicology. Through its commitment to open access, Particle and Fibre Toxicology fosters knowledge-sharing and collaboration, facilitating significant advancements in our understanding of the toxicological effects of environmental agents.

JOURNAL OF ANALYTICAL TOXICOLOGY, published by Oxford University Press Inc, stands as a leading platform in the field of analytical chemistry and toxicology, focusing on the rigorous exploration of methodologies and advancements in the detection of toxic substances. Since its inception in 1977, this journal has continually contributed to the scientific community, providing researchers and professionals with vital insights into chemical health, safety, and environmental implications. With an impressive Q1 ranking in both Analytical Chemistry and Chemical Health and Safety, along with reputable Q2 rankings in Environmental Chemistry and Toxicology, the journal maintains its critical standing in vibrant academic communities, ensuring the dissemination of high-quality research. Although it currently does not offer open access, articles are made available via institutional subscriptions, allowing widespread access to its valuable findings. Located in the United States, the journal contains a wealth of knowledge poised to benefit scientists and scholars engaged in toxicological research, emphasizing its importance in enhancing public health and safety.

Journal of Biochemical and Molecular Toxicology, published by Wiley, plays a pivotal role in the advancement of knowledge within the fields of biochemistry, toxicology, and molecular biology. Established in 1998, this esteemed journal has garnered a significant reputation, evidenced by its current placement in the Q2 quartile across several categories, including Biochemistry, Health, Toxicology and Mutagenesis, and Medicine. With an ISSN of 1095-6670 and an E-ISSN of 1099-0461, it serves an international audience, offering critical insights and innovative research that shape our understanding of biochemical interactions and toxicological assessments. While it does not operate on an open-access model, the journal ensures rigorous peer review and high-quality publication standards, making it a valuable resource for researchers, professionals, and students dedicated to the exploration of molecular toxicology. The journal's recognized impact within the scientific community is reflected in its competitive rankings among specialized journals, fostering significant contributions to both academic and applied contexts.

TOXICOLOGY IN VITRO is a premier journal published by PERGAMON-ELSEVIER SCIENCE LTD, focusing on the latest advancements in the field of toxicology, particularly through in vitro methodologies. With an ISSN of 0887-2333 and an E-ISSN of 1879-3177, this journal serves as a critical platform for researchers aiming to disseminate their findings in toxicology, emphasizing innovative approaches and applications in pharmacology and toxicology. Featuring a commendable impact factor and classified in the second quartile (Q2) for both Medicine (miscellaneous) and Toxicology in 2023, the journal holds a significant position within the academic community, ranking 41st out of 133 in the Toxicology category according to Scopus, representing the 69th percentile. Despite being a subscription-based publication, it continuously attracts submissions from leading scientists worldwide, fostering a vibrant exchange of scientific knowledge. Since its inception in 1987, TOXICOLOGY IN VITRO has consistently aimed to enhance understanding of toxicological challenges, making it an invaluable resource for professionals, students, and researchers dedicated to developing safer pharmaceuticals and understanding the biological pathways influenced by potential toxic agents.